Renovacor Reports Second Quarter 2022 Financial Results and Provides Corporate Update

REN-001 IND submission planned for the second half of 2022

Data from pilot pig study showing successful cardiac transduction with REN-001 delivered via low-dose retrograde coronary sinus infusion published in Journal of the American College of Cardiology: Basic to Translational Science

See more here


Annovis Bio Announces Second Quarter 2022 Results and Provides Corporate Update

See more here


Wellsheet Partners with athenahealth’s Marketplace Program to Improve EHR Productivity and Reduce Clinician Burnout

See more here


Concarlo Therapeutics Hires Vadim Shepel as Chief Business & Operating Officer, Completing Build-out of Company’s Core Executive Team

Senior Leader Brings Deep Biotech and Pharmaceutical Industry Experience

See more here


New Zealand Endovascular Thought Leader Joins the VESTECK Scientific Advisory Board

See more here


Senzo lands $2M investment to advance at-home tests for infectious diseases

See more here


Relmada Therapeutics Appoints Biopharmaceutical Marketing and Commercial Planning Veteran John Hixon as Head of Commercial

Company Continues Commercial Preparations in Advance of Phase III Clinical Trial Readouts for REL-1017 in Major Depressive Disorder Expected in 2022

See more here


Wellsheet Recognized as a Sample Vendor in Smart EHR UI in a Gartner Report

Smart EHR UI Critical as Healthcare Burnout and Turnover Reach Record Levels, Jeopardizing Patient Care and the Bottom Line of Health Systems

See more here


KaloCyte Closes Investment from New York Blood Center

This funding will be used to support KaloCyte as it scales up in advance of human trials

See more here